质子泵抑制剂评分制处方点评模式的建立与效果分析

Establishment and Analysis on Scoring Review Mode of Proton Pump Inhibitors Prescription

目的:探讨质子泵抑制剂评分制处方专项点评的有效性,以建立质子泵抑制剂医嘱点评的长效机制。方法:创建评分制处方点评表格及点评模式,采用此点评模式,对2015年住院病历共6248份进行点评,对质子泵抑制剂使用率、使用强度、合理率、平均分进行对照研究。结果:从2015年实施评分制处方点评模式后,住院医嘱质子泵抑制剂使用率分别从干预前65.1%,降至41.1%;合理使用率从干预前55.5%,提升到干预后的78.7%,处方平均分逐渐提高,同时评分制处方点评模式具有科学、客观,可操作性强等特点。结论:质子泵抑制剂评分制处方专项点评模式的建立与实施,促进了质子泵抑制剂合理使用,可作为质子泵抑制剂临床应用管理的长效机制。

Objective: To explore the effectiveness of the scoring review mode on prescription of Proton Pump Inhibitors and establish a longtermmechanism of prescription review. Methods: Prescription scoring form and review mode were established. Prescriptions from 6248 inpatientswere reviewed and evaluated in 2015. The percentage of Proton Pump Inhibitors usage, reasonable application rate and average score were analyzed.Results: The usage rate of Proton Pump Inhibitors in inpatients decreased from 65.1% to 41.1%, reasonable application rate increased from 55.5%to 78.7%, and average score increased gradually since scoring review system of prescription was adopted in 2015. The scoring review mode wasscientific, objective and operable. Conclusion: The establishment and implementation of scoring review mode can increase reasonable applicationrate of Proton Pump Inhibitors. This mode can be used to manage the application of Proton Pump Inhibitors as a long-term mechanism.